gene

ADRA2A

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADRA2A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

241Connections
1Hypotheses
1Analyses
50Outgoing
50Incoming

No summary available yet. View on Wiki →

🧬 Gene Info
Gene SymbolADRA2A
Target ClassGpcr
Functionis an important component in the neurobiology of neurodegenerative diseases.
Mechanism of ActionSmall molecule agonists and antagonists modulating noradrenergic signaling
DruggabilityMedium (0.59)
Clinical StageApproved
GeneCardsADRA2A
Human Protein AtlasADRA2A
Associated DiseasesALS, Alzheimer, Alzheimer'S Disease, Anxiety
Known Drugs/Compoundsmirtazapine
InteractionsADRA2B, CTSD, MAOA, RPN2, KL, ADRB1
SciDEX TargetView Target Profile (8 clinical trials)
SciDEX HypothesesNoradrenergic-Tau Propagation Blockade
KG Connections238 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (20)

Knowledge base pages for this entity

Locus Coeruleus Alpha Neurons

cell · 4048 words

Section 189: Advanced Autophagy-Endolysosomal Pathway Therapy in CBS/PSP

therapeutic · 3096 words

DNA Damage Response in Corticobasal Syndrome

mechanism · 2959 words

Locus Coeruleus Noradrenergic Neurons

cell · 2822 words

Autophagy Enhancement for Tauopathy

therapeutic · 2646 words

Pathway Diagram

graph TD
    ADRA2A["ADRA2A Gene<br/>(alpha2A-Adrenergic Receptor)"]
    
    NE["Norepinephrine<br/>Neurotransmitter"]
    SYN["Synaptic<br/>Transmission"]
    
    SLC6A2["SLC6A2<br/>(Norepinephrine Transporter)"]
    COMT["COMT<br/>(Catechol-O-Methyltransferase)"]
    
    ALZHEIMER["Alzheimer's<br/>Disease"]
    DEMENTIA["Dementia"]
    DEPRESSION["Depression"]
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    
    CHAT["CHAT<br/>(Choline Acetyltransferase)"]
    ACH["Acetylcholine<br/>System"]
    
    EPIGEN["Epigenetic<br/>Regulation"]
    THER["Therapeutic<br/>Intervention"]
    
    NE -->|"binds to"| ADRA2A
    ADRA2A -->|"inhibits"| SYN
    ADRA2A -->|"regulates"| NE
    
    SLC6A2 -->|"reuptakes"| NE
    COMT -->|"degrades"| NE
    
    ADRA2A -->|"associated with"| ALZHEIMER
    ADRA2A -->|"therapeutic target"| DEMENTIA
    ADRA2A -->|"associated with"| DEPRESSION
    ADRA2A -->|"associated with"| ALS
    
    CHAT -->|"produces"| ACH
    ADRA2A -->|"interacts with"| CHAT
    ACH -->|"cognitive function"| ALZHEIMER
    
    EPIGEN -->|"regulates"| ADRA2A
    ADRA2A -->|"target for"| THER
    
    style ADRA2A fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    style THER fill:#1b5e20,stroke:#66bb6a,stroke-width:2px
    style EPIGEN fill:#1b5e20,stroke:#66bb6a,stroke-width:2px
    style ALZHEIMER fill:#7d4200,stroke:#ff9800,stroke-width:2px
    style DEMENTIA fill:#7d4200,stroke:#ff9800,stroke-width:2px
    style DEPRESSION fill:#7d4200,stroke:#ff9800,stroke-width:2px
    style ALS fill:#7d4200,stroke:#ff9800,stroke-width:2px
    style SLC6A2 fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px
    style COMT fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px
    style CHAT fill:#4a1a6b,stroke:#ba68c8,stroke-width:2px

Outgoing (183)

TargetRelationTypeStr
ds-83b31ef18d49provides_data_fordataset1.00
Mirtazapineassociated_withdrug0.95
noradrenergic signalinginvolved_inpathway0.90
semen qualityregulatesphenotype0.80
Semen Qualityregulatesphenotype0.80

Incoming (58)

SourceRelationTypeStr
ds-83b31ef18d49data_indataset1.00
NECL1regulatesgene0.95
mirtazapinetargetsdrug0.90
h-4113b0e8targets_genehypothesis0.90
NECL1 deficiencyupregulatesphenotype0.85

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Noradrenergic-Tau Propagation Blockade 0.510 neurodegeneration Sleep disruption as cause and consequenc

Mentioning Analyses (1)

Scientific analyses that reference this entity

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.557

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 po [PMID:31227597] Snyder AG, Hubbard NW, Messmer MN, Kofma Sci Immunol 2019 1
Effect of etching with potassium hydrogen difluoride and ammonium hydrogen diflu [PMID:31068549] Akazawa N, Koizumi H, Nogawa H, Kodaira Dent Mater J 2019 1
Synapse formation in the brain can be enhanced by co-administering three specifi [PMID:29031899] Wurtman RJ Eur J Pharmacol 2017 1
Engineered AAVs for efficient noninvasive gene delivery to the central and perip [PMID:28671695] Chan KY, Jang MJ, Yoo BB, Greenbaum A, R Nat Neurosci 2017 1
The Pediatric Imaging, Neurocognition, and Genetics (PING) Data Repository. [PMID:25937488] Jernigan TL, Brown TT, Hagler DJ Jr, Aks Neuroimage 2016 1
Regulation of Lipid Biology-Associated Gene Expression in Granulosa Cells in Hyp [PMID:41605187] ["Berkel C"] Lipids 2026 0
Meta-GWAS of Pig Semen Quality Traits Reveals Conserved Genes Regulating Mammali [PMID:41504393] ["Lin Q", "Cai X", "Zhong Z", "Li T", "C Advanced science (Weinheim, Ba 2026 0
Necl1 deficiency induces noradrenergic dysfunction and depressive-like states in [PMID:41308882] ["Song J", "Wang L", "Suo J", "Ran K", " Journal of affective disorders 2026 0
The contribution of phenolic endocrine-disrupting chemicals to breast cancer ris [PMID:41673191] ["Dou Y", "Li X", "Li M", "Shang J", "Xu Scientific reports 2026 0
Transcriptomics reveals new therapeutic targets for ovarian cancer. [PMID:41577183] ["Feng Y", "Liu G"] SLAS technology 2026 0
Noradrenergic inhibition of definitive POMC neurons through direct and indirect [PMID:41877438] Lavoie O, Turmel A, Khouma A, Minbashi M Journal of neuroendocrinology 2026 0
The Neuroimmunome of Hepatitis Patients Associates With Disease Severity. [PMID:41347690] ["N\u00f3bile A", "Adri A", "Usuda J", " Journal of medical virology 2025 0
Neuro-Mesenchymal Interaction Mediated by a β2-Adrenergic Nerve Growth Factor Fe [PMID:39137067] ["Kobayashi H", "Iida T", "Ochiai Y", "M Cancer discovery 2025 0
Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and [PMID:41058112] ["Santos A", "de Souza T", "Aguiar K", " American journal of medical ge 2025 0
Probiotic Bactolac alleviates depression-like behaviors by modulating BDNF, NLRP [PMID:40281288] ["I\u015f\u0131k M", "K\u00f6se F", "Bud Pflugers Archiv : European jou 2025 0
Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Me [PMID:39962033] ["I\u015f\u0131k M", "K\u00f6se F", "\u0 Probiotics and antimicrobial p 2025 0
Unveiling the molecular mechanisms of human platelet lysate in enhancing endomet [PMID:40663777] ["Nguyen T", "Kwok Y", "Zhang C", "Russe Human reproduction (Oxford, En 2025 0
Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, [PMID:38242116] ["Ren W", "Chen J", "Wang W", "Li Q", "Y Neuron 2024 0
Enterococcus-derived tyramine hijacks α [PMID:38788722] ["Li C", "Zhang P", "Xie Y", "Wang S", " Cell host & microbe 2024 0
Tumour immune rejection triggered by activation of α2-adrenergic receptors. [PMID:37286594] Zhu J, Naulaerts S, Boudhan L, Martin M, Nature 2023 0